Graduate School of Medical Sciences
A partnership with the Sloan Kettering Institute

News

Chemotherapy drugs that target a common mutation in colorectal cancer rapidly lose efficacy in patients, leading to relapse. According to a new preclinical study by Weill Cornell Medicine and MD Anderson Cancer Center investigators, colorectal tumors often find multiple ways to survive treatment, including additional genetic mutations and activation of cellular pathways typically associated with inflammation and regeneration. Targeting this tumor-specific inflammatory process could enhance...

Read More

Weill Cornell Graduate School of Medical Sciences celebrated students in the Class of 2026 for their academic achievements during its May 13 convocation ceremony.

The ceremony, hosted by Dr. Barbara Hempstead, dean of Weill Cornell Graduate School, honored students who are graduating with their master’s and doctorate degrees, as well as those who earned special awards and prizes for their accomplishments in research, scholarship and service. The ceremony also recognized exemplary...

Read More

Video of Congratulations, Class of 2026! #graduation #classof2026 #weillcornellmedicine

When Dr. Louisa Schilling was 15 years old, she read a book called “The Brain that Changes Itself,” by Norman Doidge. Her father, who has a doctorate in microbiology and immunology, received it at a conference and it ended up in his daughter’s hands. Her immediate reaction: “I want to study the brain.”

“The book was all about neuroplasticity, and I was really taken by the idea that what...

Read More

All life forms need to continuously adapt to temperature changes to survive. Now, Weill Cornell Medicine investigators studying a bacterial protein have identified a new mechanism of sensing cold temperatures. The finding points to the possibility that this same type of mechanism exists in other organisms, including humans, and may have relevance for disorders involving faulty temperature regulation.

Dr. Crina Nimigean

Read More

A pilot program aimed at reducing Medicaid drug spending has limitations, according to a multi-institutional research team including faculty from Weill Cornell Medicine.

Launched November 2025, the GENEROUS (GENErating cost Reductions fOr U.S. Medicaid) program asks drug manufacturers to voluntarily reduce Medicaid’s prices to those paid by a group of seven peer nations including Canada, France, and the United Kingdom — a model known as Most Favored Nation pricing. States would then...

Read More

While recreational cannabis laws have significantly reduced arrests for cannabis possession and sales, racial disparities in arrests still exist, according to a new study from Weill Cornell Medicine, Instituto Tecnológico Autónomo de México and The University of Texas at Austin. The authors suggest that recreational cannabis laws do not fully resolve underlying systemic inequities.

The findings, published May 1 in the American Economic Journal: Economic Policy, provide the most...

Read More

Weill Cornell Medicine investigators have “reverse engineered” ketamine’s antidepressant effects to identify potential new strategies for treating depression.

Dr. Conor Liston. Credit: Julia Xanthos Liddy

While there are many effective treatments available for depression, not all patients respond to them. About one-third of patients must try multiple medications before eventually finding relief, and another third have treatment-...

Read More

Rows of poster boards filled the Griffis Faculty Club at Weill Cornell Medicine, showcasing research ranging from cancer immunology and microbiome science to the emerging field of space biology. Standing beside them, graduate students explained months of work in a matter of minutes, fielding questions from judges, faculty and peers.

The 45th annual Vincent du Vigneaud Memorial Research Symposium held on April 16 had a record number of 153 abstracts submitted this year, including...

Read More

Nerve fibers within melanomas can slow the growth of these tumors, according to a study led by Weill Cornell Medicine investigators. The findings help clarify the emerging field of cancer neuroscience and may inform future therapeutic strategies.

In the study, published April 29 in Neuron, the researchers used mouse models of the skin cancer melanoma to examine the presence and the effects of peripheral nerves that grow into tumors. They...

Read More

Weill Cornell Medicine investigators made an unexpected finding about how the immune system normally suppresses inappropriate chronic inflammation in the intestine, potentially opening new avenues for therapies against inflammatory bowel disease (IBD), food allergy and other autoimmune conditions.

The study, published April 24 in the Journal of Experimental Medicine, focused on the cell-to-cell signals required for the immune system to...

Read More

Weill Cornell Medicine Graduate School of Medical Sciences 1300 York Ave. Box 65 New York, NY 10065 Phone: (212) 746-6565 Fax: (212) 746-8906